ATORVASTATIN CALCIUM
- Product NDC
- 61919-632
- 11-digit product format
- 619190632
- Labeler code
- 61919
- Product ID
- 61919-632_f2151bf2-f790-5213-e053-2a95a90aaf2a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA091624
- Marketing category
- ANDA
- Marketing start
- 2018-10-31
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-632-30 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 4 |
| 61919-632-90 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-632 | ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECT RX] | 4 | Legacy NDC, 2 package rows | 20230510_7986b43a-74b5-a963-e053-2991aa0a669e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-632-30 | 61919063230 | 30 TABLET, FILM COATED in 1 BOTTLE (61919-632-30) | 2018-10-31 | 0000-00-00 | No | No | Current |
| 61919-632-90 | 61919063290 | 90 TABLET, FILM COATED in 1 BOTTLE (61919-632-90) | 2018-10-31 | 0000-00-00 | No | No | Current |